AT

Abu Taher Abdullah

Director Director DIN 10474630
DIN 10474630 First appointment Jan 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2024
Shareholding value Locked Premium profile

About Abu Taher Abdullah

Data last updated:

Abu Taher Abdullah has 2 years in corporate governance. Formerly with 1 company, such as Radial Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10474630
Primary Designation Director
First Appointment 20 Jan 2024
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director20 Jan 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Radial Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abu Taher Abdullah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abu Taher Abdullah

Abu Taher Abdullah has 2 years in corporate governance. Formerly with 1 company, such as Radial Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Abu Taher Abdullah is associated with 0 companies as a director.

Abu Taher Abdullah has expertise in General Business.

Abu Taher Abdullah has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available